MRNA Vaccines Market - Competitive Intelligence Report with Key Players and Strategies

NOIDA, India - June 7, 2023 - PRLog -- The growth can be attributed to the numerous advantages of mRNA vaccines over DNA vaccines, including production efficiency, safety, efficacy, and distribution. Factors such as the increasing incidence of cancer, genetic abnormalities, and viral infections are driving the global mRNA vaccine market. In 2020 alone, approximately 10 million deaths, accounting for nearly one in six deaths globally, were caused by cancer. mRNA vaccines, which are capable of encoding and expressing tumor-associated antigens (TAA), tumor-specific antigens (TSA), and related cytokines, represent a substantial category of cancer vaccines. Their adaptability to various diseases and patients stems from their ability to enhance both humoral and cellular immunity.

The sudden outbreak and rapid spread of the COVID-19 pandemic, coupled with the success of Moderna and Pfizer-BioNTech's COVID-19 vaccines, are expected to open new growth opportunities for the mRNA vaccine market in the coming years. Consequently, numerous biotechnology and pharmaceutical companies, as well as academic and research institutions, have initiated research and development efforts, along with the launch of clinical trials for various types of mRNA vaccines. This surge in activity is anticipated to create lucrative prospects for the global mRNA vaccine market throughout the forecast period. Clinicaltrials.gov reports that approximately 444 clinical studies related to mRNA vaccines are currently in progress across different regions of the world.

The global mRNA vaccines market can be segmented based on mRNA type, application, and region. There are three categories within the market: Nucleoside-modified mRNA, Unmodified mRNA, and Self-Amplifying mRNA. These mRNA vaccines, known as "mRNA vaccines," utilize cutting-edge technology with mRNA as the genetic component. Compared to conventional vaccines, mRNA vaccines offer enhanced immunogenicity, greater potency, rapid development, relative affordability, and improved safety, making them a highly effective alternative.

In terms of application, the global mRNA vaccines market is divided into COVID-19 mRNA vaccines and Non COVID-19 mRNA vaccines. During the COVID-19 pandemic years, specifically 2021-2022, the COVID-19 mRNA vaccine experienced significant growth due to the widespread prevalence of the virus. As the frequency of COVID-19 cases declines in comparison to the pandemic years, the Non COVID-19 mRNA vaccines are expected to witness substantial growth during the forecast period.

Major companies operating in Global mRNA Vaccines Market are:

• Arcturus Therapeutics Holdings Inc.
• BioNTech SE
• CureVac N.V.
• Daiichi Sankyo Company Limited.
• Ethris GmbH
• GlaxoSmithKline plc
• Gennova Biopharmaceuticals Ltd
• Moderna, Inc.
• Pantherna Therapeutics GmbH
• Providence Therapeutics
• Silence Therapeutics
• Translate Bio
• VERSAMEB AG
• Verve Therapeutics Inc.

Browse "Global mRNA Vaccines Market" - https://www.techsciresearch.com/report/mrna-vaccine-market/14521.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7609